I hope you are all well and have been enjoying the wonderful sunshine over the last few weeks.
Earlier this week, the University and Yorkshire Cancer Research jointly held an event to launch two new funds available to academic staff across the University. These funds are being made available exclusively to lead applicants from the University of Sheffield, utilising royalties from the PARP-Inhibitor Lynparza. We will have access to two funds:
- Fund 1 (approximately £4m) will support applications that align directly with the Yorkshire Cancer Research Strategy, and,
- Fund 2 (approximately £8m) will support applications that align with the University of Sheffield’s Cancer Research Strategy.
This is a fantastically exciting opportunity to make a step-change in cancer research in Sheffield. I am hugely grateful to our FDRI, Professor Wendy Baird who supported a multi-disciplinary team including experts from our faculty and Sheffield Teaching Hospitals NHS Foundation Trust to develop the University’s Cancer Research Strategy, and for working with Yorkshire Cancer Research on the development of these two funding programmes. This is a hugely exciting development for our faculty, the wider University and our partners. When we link together the availability of this funding, with the development of other key strategic initiatives like the new Gene Therapy Innovation and Manufacturing Centre and the Sheffield PET-MRI facility, I think it is a truly exciting time to be involved in research in Sheffield. Working with our colleagues across the university, NHS and external partners, we have a huge opportunity to improve outcomes for cancer patients regionally, nationally and internationally.
In our Spotlight this month, Michelle Nuttall, our FDO reflects on her time on adoption leave. I would very much like to welcome Michelle back to the Faculty, and also to thank her deputies Kevin Corke and Nicola Donohoe for supporting me, and the wider faculty, so well whilst she was away.
Finally, I would like to offer my congratulations again to Professor Mark Strong on his appointment as the next Dean of ScHARR. Mark will take up the post when John Brazier completes his highly successful term as Dean at the end of June. We are very much looking forward to working with Mark on the Faculty Executive.